Extendicare Inc. (TSE:EXE – Get Free Report) declared a monthly dividend on Friday, October 30th. Stockholders of record on Monday, November 16th will be given a dividend of $0.0441 per share on Monday, November 16th. This represents a $0.53 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date is Friday, October 30th.
Extendicare Trading Down 0.8%
Shares of EXE opened at C$26.90 on Wednesday. The business’s 50-day moving average price is C$29.57 and its 200-day moving average price is C$29.82. The company has a quick ratio of 0.98, a current ratio of 0.75 and a debt-to-equity ratio of 159.54. Extendicare has a twelve month low of C$15.64 and a twelve month high of C$39.14. The stock has a market cap of C$2.56 billion, a PE ratio of 20.60 and a beta of 1.39.
Extendicare (TSE:EXE – Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported C$0.38 earnings per share (EPS) for the quarter. The company had revenue of C$611.04 million during the quarter. Extendicare had a return on equity of 36.33% and a net margin of 6.13%. On average, equities analysts forecast that Extendicare will post 0.61 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on the company. National Bank Financial reduced their target price on Extendicare from C$45.00 to C$40.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 21st. Desjardins cut their price target on shares of Extendicare from C$40.00 to C$39.00 and set a “buy” rating on the stock in a report on Monday, August 10th. Royal Bank Of Canada boosted their price objective on shares of Extendicare from C$38.00 to C$39.00 and gave the company an “outperform” rating in a research report on Friday, August 14th. Finally, Canaccord Genuity Group upped their price objective on shares of Extendicare from C$37.00 to C$44.00 and gave the stock a “buy” rating in a report on Monday, August 10th. Seven research analysts have rated the stock with a Buy rating. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of C$37.00.
View Our Latest Stock Report on EXE
About Extendicare
Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. We are committed to delivering quality care to meet the needs of the growing seniors’ population, inspired by our mission to provide people with the care they need, wherever they call home. We deliver more than 27 million hours of home health care services annually, operate a network of 97 long-term care homes (58 owned, 39 under management contracts), and provide group purchasing services to third parties representing approximately 161,700 beds across Canada.
See Also
- Five stocks we like better than Extendicare
- Taiwan Semiconductor Flexes Pricing Power on AI’s Frontline
- Hidden in Plain Sight: 2 Earnings Winners Investors May Have Missed
- These 3 New ETFs Are Turning Heads—Are They Worth Buying?
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
